✦ LIBER ✦

Reversible neurotoxicity during interleukin-2 therapy for metastatic renal cell carcinoma

✍ Scribed by J.M. van Laar; M.A. van Buchem; N. Weyl; F.J. Cleton

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Interleukin-2 Therapy of Metastatic Rena

✍ David F. McDermott; Michael B. Atkins 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 106 KB

Targeted therapy for metastatic renal ce

✍ Patel, P H; Chaganti, R S K; Motzer, R J 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 112 KB

Metastatic type-2 papillary renal cell c

✍ Takeo Kosaka; Shuji Mikami; Akira Miyajima; Mototsugu Oya 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 337 KB

Interleukin-2 Therapy of Metastatic Rena

✍ David F. McDermott; Meredith M. Regan; Michael B. Atkins 📂 Article 📅 2006 🏛 CIG Media Group, LP. 🌐 English ⚖ 127 KB

Myositis associated with interleukin-2 t

✍ Francisco J. Esteva-Lorenzo; John E. Janik; Robert G. Fenton; Alison Emslie-Smit 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 529 KB

Natural history and therapy of metastati

✍ Ronald M. Bukowski 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 204 KB 👁 2 views

Despite significant advances in understanding the biology of renal